Lugli et al.30 reported that the CD8+ T cells/TB index can be used as an independent prognostic factor representing an ‘attacker-defender’ model in the TME of patients with colorectal cancer (CRC); however, to date most investigations involving TB and CD8+ T cell infiltrating PDAC have been conducted independently. Here, CD8A is linked to colorectal cancer.